| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.06 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.081 | 0.06 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.06 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |